Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism

Internal Medicine

Volumn 53, Issue 5, 2014, Pages 413-419

  Yamashita, Yoshiki ^a   Wada, Hideo ^a   Nomura, Hideki ^a   Mizuno, Toshiro ^a   Saito, Kanako ^a   Yamada, Norikazu ^a   Asanuma, Kunihiro ^a   Usui, Masanobu ^a   Kamimoto, Yuki ^a   Matsumoto, Takeshi ^a   Ohishi, Kohshi ^a   Katayama, Naoyuki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

D dimer; DIC; Malignant disease; SF; VTE

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRIN FRAGMENT D; TUMOR MARKER;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOSIS; VENOUS THROMBOEMBOLISM; BLOOD; COMPARATIVE STUDY; COMPLICATION; DISSEMINATED INTRAVASCULAR COAGULATION; FOLLOW UP; INCIDENCE; JAPAN; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; VENOUS THROMBOEMBOLISM;

EID: 84895102629     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1102     Document Type: Article

References (29)

1. Thaler J, Ay C, Pabinger I. Venous thromboembolism in cancer patients-risk scores and recent randomised controlled trials. Thromb Haemost 108: 1042-1048, 2012.
2. Wada H, Matsumoto T, Hatada T. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. Expert Rev Hematol 5: 643-652, 2012.
3. Falanga A. The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment. Cancer Invest 27: 105-115, 2009.
4. Nomura H, Wada H, Mizuno T, et al. Elevated fibrin-related markers in patients with malignant diseases suspected of having thrombotic disorders. Clin Appl Thromb Hemost 16: 266-272, 2010.
5. Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110: 1723-1729, 2007.
6. Falanga A, Barbui T, Rickles FR. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies. Semin Thromb Hemost 34: 204-210, 2008.
7. Wada H. Disseminated intravascular coagulation. CCA 344: 13-21, 2004.
8. Akl EA, Terrenato I, Barba M, Sperati F, Muti P, Schunemann HJ. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Thromb Haemost 100: 1176-1180, 2008.
9. Linkins LA, Bates SM, Ginsberg JS, Kearon C. Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability. J Thromb Haemost 2: 1256-1260, 2004.
10. Wada H, Kobayashi T, Abe Y, et al. Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis. J Thromb Haemost 6: 1253-1258, 2006.
11. Wada H, Sakuragawa N, Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost 24: 293-297, 1998.
12. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 349: 1227-1235, 2003.
13. Houbouyan-Reveillard LL, Mihoubi A, Houdijk WP, et al. Preliminary evaluation of two new rapid immunoturbidimetric Ddimer assays in patients with clinically suspected venous thromboembolism (VTE). Thromb Haemost 84: 770-774, 2000.
14. Righini M, Le Gal G, De Lucia S, et al. Clinical usefulness of Ddimer testing in cancer patients with suspected pulmonary embolism. Thromb Haemost 95: 715-719, 2006.
15. Carrier M, Lee AY, Bates SM, Anderson DR, Wells PS. Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients. Thromb Res 123: 177-183, 2008.
16. Taylor Jr FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327-1330, 2001.
17. Matsuda M, Terukina S, Yamazumi K, Maekawa H, Soe G. A monoclonal antibody that recognizes the NH2-terminal conformation of fragment D. In: Fibrinogen 4, Current Basic and Clinical Aspects. Matsuda M, Iwanaga S, Takada A, Henschen A, Eds. 1990: 43-48.
18. Goldstein BJ, Mushlin AI. Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med 2: 20-24, 1987.
19. Spencer FA, Ginsberg JS, Chong A, Alter DA. The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction. J Thromb Haemost 6: 1507-1513, 2008.
20. Wada H, Nagano T, Tomeoku M, et al. Coagulant and fibrinolytic activities in the leukemic cell lysates. Thromb Res 30: 315-322, 1982.
21. Wada H, Kumeda Y, Ogasawara Z, et al. Plasminogen activators and their inhibitors in leukemic cell homogenates. Am J Hematol 42: 166-170, 1993.
22. Kaido T, Oe H, Yoshikawa A, Mori A, Arii S, Imamura M. Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors. Hepatogastroenterology 52: 1383-1387, 2005.
23. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105: 1785-1790, 2002.
24. Saray A, Mesihovic R, Gornjakovic S, et al. Association between high D-dimer plasma levels and ascites in patients with liver cirrhosis. Med Arh 66: 372-374, 2012.
25. Dempfle CE. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state. Thromb Haemost 82: 673-683, 1999.
26. Minamikawa K, Wada H, Wakita Y, et al. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. Thromb Haemost 71: 192-194, 1994.
27. Yamada N, Wada H, Nakase T, et al. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis. Blood Coag Fibr 6: 627-633, 1995.
28. Wada H, Mori Y, Shimura M, et al. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. Am J Hematol 58: 189-194, 1998.
29. Wada H, Mori Y, Kaneko T, et al. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia. Am J Hematol 44: 112-116, 1993.